Filtered By:
Specialty: Internal Medicine
Condition: Bleeding
Drug: Doxycycline
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
Vascular malformations in hereditary hemorrhagic telangiectasia (HHT) lead to chronic recurrent bleeding, hemorrhage, stroke, heart failure, and liver disease. There is great interest in identifying novel ther...
Source: Orphanet Journal of Rare Diseases - November 7, 2022 Category: Internal Medicine Authors: K. P. Thompson, J. Sykes, P. Chandakkar, P. Marambaud, N. T. Vozoris, D. A. Marchuk and M. E. Faughnan Tags: Research Source Type: research
